Pharma in Brief
AUGUST 9, 2021
On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. Health Canada is accepting comments on the Minister of Health’s proposal to amend the FDR and the Medical Devices Regulations until October 28, 2021.
XTalks
FEBRUARY 8, 2024
In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 percent in the US, impacted by prior formulary losses as well as “erosion of the basal insulin market,” the company said in the statement. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
MAY 14, 2021
It may also improve your sensitivity to insulin, which means it works better in your body. Talk to your doctor about whether you need to adjust your meds or insulin dose to keep your levels high enough. When you drink, the liver has to work to remove the alcohol from the blood instead of regulating blood sugar.
pharmaphorum
JUNE 18, 2021
Teasing out complex relationships within data lies at the heart of any digital health intervention, but finding the algorithms to do so reliably – and making sure they will be acceptable to regulators – can be a challenge. The algorithms used in healthcare are becoming more complex as well.
The Pharma Data
MAY 15, 2021
Page 89 – Learn about the delicious drink that raises metabolic rate, helps remove abdominal fat, boosts muscle growth, reduces resistance to insulin, strengthens the immune system and lowers food allergy reactions, has all 37 vitamins, minerals, and amino acids. You are going to be shocked to know what it is.
The Pharma Data
AUGUST 3, 2021
The company confirmed the tirzepatide SURPASS program has met global regulatory submission requirements for evaluating cardiovascular risk and its intention to submit the registration package to regulatory authorities by the end of 2021. 25% $ 2,988.1 $ 2,459.1 22% Humalog ®(a) 607.6 2)% Alimta 610.6 6% Taltz 569.1 26% Humulin ® 315.3
XTalks
AUGUST 2, 2023
2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. a month for either 150 mg or 300 mg dose strength packages, and $3,462.13
Expert insights. Personalized for you.
98 
Let's personalize your content